<?xml version="1.0" encoding="UTF-8"?>
<p class="p">In recent years, the incidence of fungal infections especially 
 <italic class="italic">Candida</italic>-related disorders termed generally as “candidiasis” has increased dramatically in many countries [
 <xref rid="B8-molecules-22-02095" ref-type="bibr" class="xref">8</xref>]. On the other hand, it is known that disseminated infections with 
 <italic class="italic">C. albicans</italic> cause significant morbidity and mortality among immunocompromised individuals, such as Human Immunodeficiency Virus (HIV) patients, transplant recipients, and cancer patients [
 <xref rid="B8-molecules-22-02095" ref-type="bibr" class="xref">8</xref>,
 <xref rid="B9-molecules-22-02095" ref-type="bibr" class="xref">9</xref>,
 <xref rid="B10-molecules-22-02095" ref-type="bibr" class="xref">10</xref>,
 <xref rid="B11-molecules-22-02095" ref-type="bibr" class="xref">11</xref>]. Furthermore, progression of the yeast with increasing the resistance of therapeutic conventional medicine increased the need for the most effective treatment [
 <xref rid="B5-molecules-22-02095" ref-type="bibr" class="xref">5</xref>].
</p>
